Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Immortalized Human Ear Epithelial Cell Line.

  • Read more about Immortalized Human Ear Epithelial Cell Line.
Patent Cooperation Treaty
PCT/US00/014751
Filed on 2000-05-26

Transition Metal Complexes of N ,N',N-Trialkyl-CIS,CIS-1,3,5- Triaminocyclohexane & Related Compositions & Methods of Synthesis and Use

  • Read more about Transition Metal Complexes of N ,N',N-Trialkyl-CIS,CIS-1,3,5- Triaminocyclohexane & Related Compositions & Methods of Synthesis and Use
Patent Cooperation Treaty
PCT/US2000/021957
Filed on 2000-08-10

Novel 2-Alkoxy Estradiols and Derivatives Thereof

  • Read more about Novel 2-Alkoxy Estradiols and Derivatives Thereof
US Patent 6,136,992
Filed on 1998-03-12

Transfer Microdissection

  • Read more about Transfer Microdissection
Patent Cooperation Treaty
PCT/US2001/008095
Filed on 2001-03-14

Molecular Motor

  • Read more about Molecular Motor
Patent Cooperation Treaty
PCT/US00/20925
Filed on 2000-07-31

T20/D178 And T21/D107 Are Activators of Human Phagocyte Formyl Peptide Receptors

  • Read more about T20/D178 And T21/D107 Are Activators of Human Phagocyte Formyl Peptide Receptors
Patent Cooperation Treaty
PCT/US2000/012371
Filed on 2000-05-05

Cloning and Characterization of ILP2 and ILP3

  • Read more about Cloning and Characterization of ILP2 and ILP3
Patent Cooperation Treaty
PCT/US00/26735
Filed on 2000-09-29

Cloning and Characterization of VIAF in Several Organisms

  • Read more about Cloning and Characterization of VIAF in Several Organisms
Patent Cooperation Treaty
PCT/US00/20576
Filed on 2000-07-28

Polypeptides Comprising IL-6 Ligand-Binding Receptor Domains and Relat ed Nucleic Acids, Antibodies, Compositions and Methods of Use

  • Read more about Polypeptides Comprising IL-6 Ligand-Binding Receptor Domains and Relat ed Nucleic Acids, Antibodies, Compositions and Methods of Use
Patent Cooperation Treaty
PCT/US00/23490
Filed on 2000-08-25

Pharmaceutical Composition Comprising 2,4-Diamino-6-Benzyloxy-S- Triazine And Inactivation of O6-Alkylguanine-DNA-Alkyltransferase

  • Read more about Pharmaceutical Composition Comprising 2,4-Diamino-6-Benzyloxy-S- Triazine And Inactivation of O6-Alkylguanine-DNA-Alkyltransferase
US Patent 6,303,604
Filed on 2000-06-09

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1502
  • Page 1503
  • Page 1504
  • Page 1505
  • Page 1506
  • Page 1507
  • Page 1508
  • Page 1509
  • Page 1510
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health